mTORC2 controls cancer cell survival by modulating gluconeogenesis

For rapid tumor growth, cancer cells often reprogram the cellular metabolic processes to obtain enhanced anabolic precursors and energy. The molecular changes of such metabolic rewiring are far from established. Here we explored the role of mTOR (mechanistic target of rapamycin), which serves as a k...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, MW, Biswas, D, Ghosh, M, Mandloi, S, Chakrabarti, S, Chakrabarti, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979518/
https://www.ncbi.nlm.nih.gov/pubmed/27551450
http://dx.doi.org/10.1038/cddiscovery.2015.16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979518/
https://www.ncbi.nlm.nih.gov/pubmed/27551450
http://dx.doi.org/10.1038/cddiscovery.2015.16

Ejemplares similares